Awasthi, S., Maity, T., Oyler, B. L., Qi, Y., Zhang, X., Goodlett, D. R., & Guha, U. (2018). Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma. J Proteomics.
Chicago Style citaatAwasthi, Shivangi, Tapan Maity, Benjamin L. Oyler, Yue Qi, Xu Zhang, David R. Goodlett, en Udayan Guha. "Quantitative Targeted Proteomic Analysis of Potential Markers of Tyrosine Kinase Inhibitor (TKI) Sensitivity in EGFR Mutated Lung Adenocarcinoma." J Proteomics 2018.
MLA citatieAwasthi, Shivangi, et al. "Quantitative Targeted Proteomic Analysis of Potential Markers of Tyrosine Kinase Inhibitor (TKI) Sensitivity in EGFR Mutated Lung Adenocarcinoma." J Proteomics 2018.